Follow us on:
Breaking News
August 17, 2026
Breaking News
Breaking News
Federal Equipment_CP_Leaderboard_8/17/26

Henlius, Sandoz Expand Oncology Biosimilars Partnership with mAbs, ADCs

 
Henlius, Sandoz Expand Oncology Biosimilars Partnership with mAbs, ADCs

Henlius grants Sandoz exclusive registration and commercialization rights, outside China, for up to 10 products.
Read More >>

Headlines

Breaking News

Lonza Launches Rapid Media Prototyping Service

New RaMP service provides custom liquid and powder media batches within 10 working days.

SPONSOR

An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer

Lifecore Injectables CDMO experts share what it really takes to get tech transfer right. Download the free eBook and set your program up for success.

Breaking News
Promotions & Moves

ACG Appoints Rajesh Bhogavalli as Group Chief Commercial Officer

Bhogavalli offers more than 30 years' experience in commercial strategy, global supply chain and business transformation.

Breaking News

IASO Bio Acquires MediSix Therapeutics

Deal adds MediSix’s PEBL platform, T-cell engineering expertise, and clinical-stage pipeline to IASO Bio’s global cell therapy strategy.

SPONSOR

The Next Layer: Evolving Trends in Topical Drug Delivery and Outsourcing

Advances in formulation science, quality excipients, and integrated outsourcing models are transforming how drugs are delivered through the skin. Learn how CDMOs and suppliers like gChem are helping sponsors navigate the shift.

ContractPharma_Conference_2026_650x250

Breaking News

Aurisco Yangzhou Site Passes FDA Inspection

Inspection covered oligonucleotides, GLP-1 peptides and small molecules.

Featured Resources

Solution Center SPOTLIGHT

Sino Biological

Sino Biological is a leading global CRO with 18+ years’ expertise in protein production and antibody development. Our proprietary recombinant production platforms enable efficient HTP expression to kg-scale manufacturing. We offer integrated services from antibody discovery to engineering and production, accelerating your path from bench to clinic.

 

Solution Center SPOTLIGHT

Suanfarma CDMO

Suanfarma CDMO provides integrated, end-to-end solutions for development and commercialization services of Intermediates and Drug Substances for Small Molecules. We specialize helping pharmaceutical, biotech and healthcare companies delivering full integrated services that compress timelines to market maximizing success. We have the best know-how and technologies to carry out fermentation, purification, and chemical synthesis processes in our CDMO plants including Regulatory support.